Sensitizers and protectors in clinical oncology

A noninvasive eye fixation monitoring system for CyberKnife radiotherapy of choroidal and orbital tumors.

Medical physics·2009

Economic evaluation of interventions to reduce road traffic injuries--a review of the literature with applications to low and middle-income countries.

Asia-Pacific journal of public health·2008

Peripheral dose in ocular treatments with CyberKnife and Gamma Knife radiosurgery compared to proton radiotherapy.

Physics in medicine and biology·2007

Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme.

International journal of radiation oncology, biology, physics·2001

Toxicity following high-dose three-dimensional conformal and intensity-modulated radiation therapy for clinically localized prostate cancer.

Urology·2001

A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003.

International journal of radiation oncology, biology, physics·2000

Integrating patient-reported outcomes into explainable machine learning models for long-term survival prediction in TKI-treated metastatic renal cell carcinoma.

Seminars in oncology·2026

Tumour immunotherapy in solid and hematologic malignancies: Progress, challenges, and a practical framework.

Seminars in oncology·2026

Single-cell sequencing in pan-cancer research: Decoding heterogeneity, tumor microenvironment, and clinical translation.

Seminars in oncology·2026

Atezolizumab, lurbinectedin, tarlatamab, and FOLFIRNOX in a patient with metastatic small cell carcinoma of the anal canal: A case report and review of the literature.

Seminars in oncology·2026

Uncovering an uncommon diagnosis: Encapsulated papillary carcinoma of the male breast in a Jordanian patient-A case report.

Seminars in oncology·2026

Silver nanoparticles in tumor microenvironment modulation: Mechanistic insights, preclinical evidence, and translational challenges.

Seminars in oncology·2026

A descriptive histopathological framework for radiotherapy-related muscle injury in salvage surgery for hypopharyngeal cancer.

Acta oto-laryngologica·2026

Contrast-enhanced ultrasound-based energy response phenotyping in thyroid nodule ablation: identifying heterogeneous subgroups via latent class analysis.

Quantitative imaging in medicine and surgery·2026

A lightweight deep learning model for automated segmentation of Gynecologic organs and cervical Tumors on T2-weighted magnetic resonance imaging.

Physics and imaging in radiation oncology·2026

An Enzymatic in situ Self-Assembly Radiosensitizer for Hypoxic Tumor Radio-Immunotherapy via Low-Power X-ray-Induced Pyroptosis.

Journal of the American Chemical Society·2026

Cisplatin enhances radiation-induced apoptosis in peripheral lymphocytes of cancer patients: in vivo and in vitro findings.

Radiation oncology (London, England)·2026

Gastrointestinal perforation associated with bevacizumab and palliative radiotherapy.

International journal of clinical oncology·2026

Related Experiment Videos

Sensitizers and protectors in clinical oncology

Related Concept Videos

A noninvasive eye fixation monitoring system for CyberKnife radiotherapy of choroidal and orbital tumors.

Economic evaluation of interventions to reduce road traffic injuries--a review of the literature with applications to low and middle-income countries.

Peripheral dose in ocular treatments with CyberKnife and Gamma Knife radiosurgery compared to proton radiotherapy.

Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme.

Toxicity following high-dose three-dimensional conformal and intensity-modulated radiation therapy for clinically localized prostate cancer.

A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003.

Integrating patient-reported outcomes into explainable machine learning models for long-term survival prediction in TKI-treated metastatic renal cell carcinoma.

Tumour immunotherapy in solid and hematologic malignancies: Progress, challenges, and a practical framework.

Single-cell sequencing in pan-cancer research: Decoding heterogeneity, tumor microenvironment, and clinical translation.

Atezolizumab, lurbinectedin, tarlatamab, and FOLFIRNOX in a patient with metastatic small cell carcinoma of the anal canal: A case report and review of the literature.

Uncovering an uncommon diagnosis: Encapsulated papillary carcinoma of the male breast in a Jordanian patient-A case report.

Silver nanoparticles in tumor microenvironment modulation: Mechanistic insights, preclinical evidence, and translational challenges.

A descriptive histopathological framework for radiotherapy-related muscle injury in salvage surgery for hypopharyngeal cancer.

Contrast-enhanced ultrasound-based energy response phenotyping in thyroid nodule ablation: identifying heterogeneous subgroups via latent class analysis.

A lightweight deep learning model for automated segmentation of Gynecologic organs and cervical Tumors on T2-weighted magnetic resonance imaging.

An Enzymatic in situ Self-Assembly Radiosensitizer for Hypoxic Tumor Radio-Immunotherapy via Low-Power X-ray-Induced Pyroptosis.

Cisplatin enhances radiation-induced apoptosis in peripheral lymphocytes of cancer patients: in vivo and in vitro findings.

Gastrointestinal perforation associated with bevacizumab and palliative radiotherapy.

Related Experiment Videos

Sensitizers and protectors in clinical oncology

Related Concept Videos

Related Articles